| Body na spoluautora | Body za publikaci pro MU | Odkaz ISVaV | | 6,34 | 31,72 | Matrix metalloproteinase-2 promoter variability in psoriasis
|
| 11,82 | 59,08 | Association of the Cluster of Genetic Risk Factors in Loci Related to Glycoxidation with Diabetic Nephropathy in Type 2 Diabetes Mellitus
|
| 0,00 | 0,00 | Activities of antioxidative enzymes and lipoperoxidation in patients after tracheotomy
|
| 9,78 | 58,70 | Genetic variability in the pentose phosphate cycle enzymes as a treatment-independent modifier of hyperglycemia toxicity in diabetic nephropathy
|
| 6,37 | 31,83 | Genetic variations and plasma levels of the Gelatinase A (matrix metalloproteinase-2) and Gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
|
| 35,99 | 107,98 | Functional analysis of the susceptibility haplotype in the Receptor for Advanced Glycation End-products gene and its role in the hyperglycemia-driven pathology
|
| 2,13 | 12,78 | Is there any link between severe pre-eclampsia and defined polymorphisms in leptin and adiponectin genes?
|
| 8,69 | 26,07 | Haplotype analysis of the NADPH oxidase p22phox gene in patients with bronchial asthma
|
| 1,37 | 9,57 | Elevated Malondialdehyde Correlates with the Extent of Primary Tumor and Predicts Poor Prognosis of Oropharyngeal Cancer
|
| 5,62 | 5,62 | Molekulární patofyziologie pozdních komplikací diabetu mellitus - genetická predispozice k rozvoji diabetických komplikaci
|
| 125,39 | 125,39 | Genetic variability in the RAGE gene: Possible implications for nutrigenetics, nutrigenomics and understanding the susceptibility to diabetic complications
|
| 0,31 | 2,81 | Identifikace genetických rizikových faktor diabetické nefropatie u T2DM v genech pro EDN1, LTA, RAGE a NOS3 pomocí multilokusové analýzy
|
| 13,53 | 54,11 | Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus
|
| 11,32 | 33,97 | Functional polymorphism in the manganese superoxide dismutase (MnSOD) gene in patients with asthma
|
| 41,05 | 41,05 | Evaluation of migration-stimulating factor expression for breast cancer diagnosis and prognosis
|
| 0,00 | 0,00 | ELEVACE OXIDATIVNÍHO STRESU U PACIENTŮ SE SPINOCELULÁRNÍM KARCINOMEM HLAVY A KRKU
|
| 5,26 | 26,28 | Haplotype analysis of the region of 6p chromosome spanning the AGER – TNFA – LTA – NFKBIL1 – BAT1 loci: Preliminary results of association study with diabetic nephropathy and retinopathy
|
| 26,31 | 78,93 | Increased plasma levels of sRAGE in patients with diabetic nephropathy
|
| 0,00 | 0,00 | Korelace zvýšeného oxidativního stresu s negativní prognózou u spinocelulárního karcinomu hlavy a krku
|
| 0,00 | 0,00 | OXIDATIVNÍ STRES JAKO NEGATIVNÍ PROGNOSTICKÝ FAKTOR U SPINOCELULÁRNÍHO KARCINOMU HLAVY A KRKU
|
| 0,00 | 0,00 | Oxidativní stres a spinocelulární karcinom hlavy a krku
|
| 0,00 | 0,00 | Parametry oxidativního stresu předpovídající výsledek onkoterapie karcinomu ústní dutiny a orofarynxu
|
| 0,00 | 0,00 | Perioperační hladina malondialdehydu jako prognostický onkologický marker časné recidivy u orofaryngeálních karcinomů
|
| 0,00 | 0,00 | Malondialdehyde as a prognostic parameter in squamous cell carcinoma of oral cavity and oropharynx
|
| 0,00 | 0,00 | Prediktivní hodnota hladiny oxidativního stresu u spinocelulárních karcinomů dutiny ústní a orofaryngu
|
| 0,00 | 0,00 | Prediktivní hodnota hladiny oxidativního stresu u spinocelulárního karcinomu dutiny ústní a orofaryngu
|
| 1,04 | 5,20 | Soluble RAGE, diabetic nephropathy and genetic variability in the AGER gene
|
| 19,15 | 191,53 | Thiamine Status and Genetic Variability in the Pentose Phosphate Cycle Enzymes as Risk Factors for Diabetic Nephropathy
|
| 2,81 | 5,62 | Variabilita antioxidačních a reparačních enzymů a parametry oxidačního stresu a reparace DNA u diabetu mellitus
|
| 32,10 | 32,10 | Co-Expression by Keratinocytes of Migration Stimulating Factor (MSF) and a Functional Inhibitor of its Bioactivity (MSFI)
|
| 1,33 | 8,00 | Increased activity of superoxid dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases
|
| 0,00 | 0,00 | Haplotype analysis of NADPH oxidase p22phox gene in Czech patients with bronchial asthma
|
| 10,82 | 54,11 | Haplotype-based association study between the region of 6p chromosome spanning the AGER - TNFA - LTA - NFKBIL1 - BAT1 and diabetic nephropathy
|
| 7,18 | 64,58 | Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach
|
| 2,12 | 10,58 | Genetic variation and plasma level of the basic fibroblast growth factor in proliferative diabetic retinopathy
|
| 3,05 | 12,20 | HFE C282Y gene variant is a risk factor for the progression to decompensated liver disease in chronic viral hepatitis C subjects in Czech population
|
| 0,00 | 0,00 | Genetická variabilita transketolázy a diabetická nefropatie - pilotní studie
|
| 117,30 | 117,30 | Diabetic threesome (hyperglycemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
|
| 1,87 | 5,62 | Diabetická nefropatie- renální funce a hladina sRAGE, genet. variabilita AGER genu
|
| 1,40 | 5,62 | Diabetická nefropatie, solubilní RAGE a genetická variabilita AGER genu
|
| 0,00 | 0,00 | Nutrient-gene interactions in diabetes - advanced glycation end products (AGEs)
|
| 23,00 | 69,00 | "SNPs in adipokines - adiponectin and leptin - as risk factors for diabetic complications: evidence for a ""double-hit"" mechanism?"
|
| 0,00 | 0,00 | Transketolase (TKT) gene variability as a potencial susceptibility factor for diabetic nephropathy
|
| 0,00 | 0,00 | Relationship between circulating levels of soluble RAGE (sRAGE) and genetic variability in the AGER gene in subjects with diabetic nephropathy
|
| 1,87 | 5,62 | Role genetické variability vybraných antioxidačních enzymů u diabetické nefropatie - pilotní výsledky
|
| 26,31 | 78,93 | Role of genetic variability in antioxidant and DNA reparation enzymes in diabetic nephropathy
|
| 0,00 | 0,00 | A keratinocyte-produced inhibitor is differentially active against two isoforms of MSF
|
| 0,00 | 0,00 | Antioxidant and DNA reparation enzyme genetic polymorphism as a pathogenic factor of diabetic nephropathy
|
| 5,85 | 23,40 | Vybrané přednášky z prediktivní genetiky
|
Back
(c) Michal Bulant, 2011